Is a high triglycerides/low HDL pattern a marker of elevated VLDL remnants and insulin resistance even when fasting insulin and HbA1c are normal?

The pattern of high triglycerides (TG) and low HDL cholesterol (HDL-C) is a well-established clinical indicator of both atherogenic lipoprotein profiles and underlying metabolic dysfunction. This lipid ratio serves as a robust proxy for the presence of remnant lipoproteins and frequently identifies insulin resistance (IR) in individuals who maintain normal glycemic markers such as fasting insulin and HbA1c.

Clinical and Effectiveness Evidence

The TG/HDL-C ratio is a validated surrogate for insulin sensitivity, often correlating strongly with the hyperinsulinemic-euglycemic clamp—the gold standard for measuring IR.

• Early Detection: Research in normoglycemic adults indicates that a high TG/HDL-C ratio (typically >2.27 to 3.0, depending on the population) predicts IR even when HbA1c remains below the prediabetic threshold of 5.7%.
• Predictive Power: In clinical cohorts, this lipid pattern has been shown to outperform individual measurements of TG or HDL alone in identifying "metabolically obese" individuals who appear healthy by standard glucose metrics but harbor significant metabolic risk.
• Remnant Association: High TG levels consistently reflect an accumulation of VLDL1 particles and their remnants (RLP-C). Ratios exceeding 2.0 mg/dL are highly specific for the "atherogenic dyslipidemia" phenotype, characterized by elevated remnants and small, dense LDL particles.

Mechanistic Explanations

The association between this lipid pattern and insulin resistance is driven by specific metabolic pathways in the liver and adipose tissue:

• VLDL Overproduction: Insulin resistance in adipose tissue increases the flux of free fatty acids (FFAs) to the liver. This stimulates the overproduction of large, triglyceride-rich VLDL1 particles.
• Impaired Clearance: IR also reduces the activity of lipoprotein lipase (LPL), the primary enzyme responsible for clearing triglycerides from the blood. This leads to a buildup of VLDL remnants.
• CETP-Mediated Exchange: Elevated triglycerides trigger the activity of cholesteryl ester transfer protein (CETP), which exchanges TG from VLDL for cholesterol esters in HDL. These TG-enriched HDL particles are rapidly degraded by hepatic lipase, resulting in the characteristic low HDL-C levels.
• Atherogenic Remnants: The resulting VLDL remnants are cholesterol-enriched and highly atherogenic, as they can be taken up directly by macrophages in the arterial wall without needing further modification.

Bottom line

A high TG/low HDL pattern is a sensitive marker for elevated remnant lipoproteins and underlying insulin resistance. It is particularly valuable for identifying metabolic risk in patients who still exhibit normal fasting insulin and HbA1c levels, as dyslipidemia often precedes overt hyperglycemia in the progression of metabolic syndrome.